SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Lucintel | PRODUCT CODE: 2185440

Cover Image

PUBLISHER: Lucintel | PRODUCT CODE: 2185440

Biopharma Plastic Market Report: Trends, Forecast and Competitive Analysis to 2035

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 3 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 4850
PDF, Excel & 1 Year Online Access (2-5 User License)
USD 6700
PDF, Excel & 1 Year Online Access (Corporate License)
USD 8850
PDF, Excel & 1 Year Online Access (Global License)
USD 10000

Add to Cart

Biopharma Plastic Market

The future of the global biopharma plastic market looks promising with opportunities in the protective wear, container, bioreactor bag, syringe, depth filter, and disposable medical connector markets. The global biopharma plastic market is expected to reach an estimated $14.2 billion by 2035 from $7.7 billion in 2027 with a CAGR of 8.1% from 2027 to 2035. The major drivers for this market are the increasing demand for single-use bioprocess systems, the rising adoption of advanced medical packaging materials, and the growing use of plastics in biopharmaceutical manufacturing.

  • Lucintel forecasts that, within the product type category, polyvinyl chloride is expected to witness the highest growth over the forecast period due to superior processability preferred in PVC biopharma plastic systems.
  • Within the application category, syringes is expected to witness the highest growth over the forecast period due to expanding syringe production requiring biopharma plastic materials.
  • In terms of regions, North America is expected to witness the highest growth over the forecast period due to established medical device sector and continuous plastic packaging demand.

Emerging Trends in Biopharma Plastic Market

The biopharma plastic market is expected to shift from volume-led consumables to qualified systems, with the growth of biologics and cell and gene therapies. Around 2025-2027, competition will exist in the market for extractables control, supply assurance, automation, and integration with the environment. Lucintel expects a more specification-driven and regionally diverse market.

  • Sustainability: Buyers are seeking lower-resin designs and life-cycle evidence. The EU Packaging and Packaging Waste Regulation came into force on February 11, 2025, and will raise expectations on packaging. By 2025, qualification decisions will be driven by carbon and disposal data.
  • Single-use Expansion: Flexible bags, tubing, and assemblies have displaced stainless-steel steps. According to BioPlan Associates' 2025 survey, single-use bioreactors are at 92% and demand is expected to be strong from 2025-2027. This trend, however, will require data on the extractables of the film and film integrity over the next five years.
  • Automation Compatibility: Plastic components allow for continuous monitoring and robotic filling. In January 2025, an FDA discussion paper addressed AI in drug manufacturing. The ability to meet specific and more exacting requirements will allow qualified suppliers to differentiate from a commodity converter over the next five years.
  • Functional Materials: COC/COP and other films that allow for low protein binding are being considered in applications where protein binding is a concern. In 2024, West had sales of $2.9 billion. Balancing the requirements above will be necessary over the next five years.
  • Regional Supply Diversification: There is a trend to add qualified supply in North America and Europe. This is especially true with the recent scrutiny on U.S. policies and demand for local manufacturing. Dual sourcing and regional inventories will be the norm with the next five years to account for unexpected component shortages.

During the next three years, suppliers will need to balance performance with environmental data and reliable delivery. The strongest demand will be single-use bioprocessing, advanced therapies and high-containment manufacturing. Plastic will allow buyers to accept higher prices over the planning horizon when it reduces batch risk, qualification time or exposure to disposal of toxic byproducts.

Recent Developments in the Biopharma Plastic Market

We anticipate positive market trends for biopharma plastics from 2025 to 2027, driven by growth in single-use systems, pharmaceutical-grade packaging, and high-performance polymer components for biologics, vaccines, cell and gene therapies and advanced drug manufacturing. According to Lucintel, the market will shift toward plastics that improve sterility and reduce risks of contamination and support flexible and manufacturing while fulfilling the requirements of stringent sustainability and regulations.

  • Use of Single-use Technologies: Expanding use of single-use bioprocessing bags, tubing and connectors, filters and other plastic components in bioprocessing systems is expected to increase. Single-use systems can eliminate the need for system cleaning and sterilization and shorten manufacturing change over time, thus reducing cross contamination risk, particularly for biologics and small batch production.
  • Expanding Biologics and Advanced Therapies: The continued development of monoclonal antibodies and other vaccines and recombinant proteins as well as cell and gene therapies are expected to increase the overall demand for biopharmaceuticals. Along with other traditional drug products, the continued expansion of biologics, recombinant proteins, and other products will support the need for single use systems within the biopharmaceutical industry.
  • Developments in High-performance Polymers: The use of higher performance polymers and materials, including cyclic olefin polymers/copolymers, polycarbonate, and polyolefins, as well as fluoropolymers, in drug containers, diagnostic and other components and systems in the biopharmaceutical industry is expected to increase over the next few years. Chemical and functional performance, as well as clarity and dimensional stability, of polymers and other materials will support their broader use in controlled and regulated manufacturing environments.
  • Increasing Demand for Pharmaceutical Packaging: The continued development of injectable and other drug products that require specialized and/or controlled packaging is expected to increase the overall demand for plastics in pharmaceutical packaging. Thinner walls and higher impact resistance of plastics as compared to other packaging materials provide added benefits for packaging of sensitive drugs. Improvements in polymer performance are expected to address product protection concerns.
  • Sustainability and Plastic Waste: Regulatory and environmental pressures will lead biopharmaceutical companies to consider the lifecycle of single-use plastics. There are several options to address plastic waste in biopharmaceutical manufacturing. These include reducing the use of plastics, improving the recyclability of materials, improving waste separation and recovery, and optimizing the design of systems. Investments in plastics and other materials will be made to ensure the sterility and performance of pharmaceutical manufacturing.

The market for biopharma plastics is expected to grow. Advances in polymer science have led to the development of higher purity and more robust polymer systems. As single-use biopharmaceutical manufacturing continues to grow and advanced therapies are commercialized, the demand for specialized plastic components is also expected to grow. Given the anticipated return on investment, it is expected that first movers in the adoption of specialized biopharmaceutical plastics will be biologics, vaccine, cell and gene therapy, and other advanced pharmaceutical manufacturing companies.

Strategic Growth Opportunities in the Biopharma Plastic Market

The biopharma plastic market is in a stronger commercial cycle as the increase in demand for sterile, single-use components for injectable biologics and cell and gene therapies, as well as growth in decentralized manufacturing. Supply gaps are filled through capacity additions. Lucintel is bullish on the shift of value toward validated materials and application-specific formats as well as service contracts.

  • Single-use Bioprocessing: Contract manufacturers are replacing stainless-steel trains with bags and tubing. Sartorius projected €3.39 billion in revenue by 2025 from its biologics business. Demand for plastics will continue to be pulled toward integrated, validated systems through 2030.
  • Advanced Drug-delivery Formats: The FDA's Jan 2025 review indicated 50 novel drug approvals in 2024. The polymer containers and devices used to manufacture these drugs will be in high demand in the next 5 years. Devices such as wearable injectors and prefilled syringes require rigorous tests for dimensional control and extractables.
  • Regional Manufacturing: There is demand for local production of sterile components in India and Southeast Asia. The Indian pharmaceutical market is expected to grow to $130 billion by 2030. With the expansion of local production, it will create a demand for compliant plastic conversion.
  • Recyclable and Lower-impact Materials: Customers are asking for lower waste, recycled content, and mono-materials in designs where validated. The EU Packaging and Packaging Waste Regulation (2019/881) aims for 100% recyclability of packaging by 2030. With these new standards, procurement will direct biopharma plastics toward lower impact and more circular designs.
  • Digital Quality Services: Automated systems and digital records allow for easier tech transfer and lower the cost of quality. There were 22 novel drug approvals under the accelerated approval pathway listed by FDA's CDER in Mar 2025. Shorter development cycles mean increased demand for more customized, traceable, and validated plastics.

Demand will mainly be in countries where biologics manufacturing is ramping up and where devices formats are becoming more advanced. The gap between traditional, commoditized plastics and qualified systems is the biggest opportunity for growth. Long-term contracts, higher margins, and customer retention will be the result for companies that can fill this gap.

Biopharma Plastic Market Drivers and Challenges

The plastic biopharma market is driven and impacted by various integration of technological, economic, regulatory, and environmental factors. On the other hand, diversity and environmental impacts create challenges. Lucintel sees positive and innovative technologies that balance pressure for rapid change against compliance with emerging standards for sustainability and quality.

The factors responsible for driving this market include:

  • Customer Demand: The need for biopharmaceuticals (biologics, vaccines, and injectable drugs), and other personalized medicines, has increased the need for plastic components such as bags, tubing, syringes, vials, and cartridges, among others. In January 2025, the U.S. Food and Drug Administration (FDA) announced 50 new drug approvals for that year, illustrating the commitment of the pharmaceutical industry to innovate and manufacture new medicines. Within the next three to five years, the expansion of drug pipelines will require biopharma manufacturers to use more lightweight, scalable, and disposable plastic components to package and process medicines, thus fostering market growth.
  • Single-Use Technology: Compared to traditional stainless-steel systems, single-use plastic systems have reduced requirements for cleaning, sterilization, cross-contamination, and validation. In addition, flexible systems allow manufacturers to rapidly change and adapt production lines to accommodate various drugs. In May 2026, the U.S. Pharmacopoeia (USP) will publish General Chapter 665, which will address control of plastics used in pharmaceutical and biopharmaceutical manufacturing. Also in the next three to five years, improved qualification and acceptance of single-use systems are expected, which will favor the biopharma plastics market.
  • Product Innovation: Manufacturers have produced multilayer films, high-performance tubing, and polymer materials that increase drug stability and process performance. They do this by reducing factors such as adsorption and packaging-related losses. Furthermore, 2025 single-use bioreactors maintained the capability to support ~2,000 liters. This illustrates the increasing capacity limits of single-use bioprocessing. With the current trend in material innovation, plastics will be suitable for more demanding applications with regard to sensitivity and potency, such as certain biologics (i.e. cell and gene therapies and other highly potent products).
  • Manufacturing Efficiency: Biopharma plastics improve manufacturing efficiency by decreasing equipment turnaround time, water and chemicals consumption, and building construction costs. Bioprocessing plastics and systems promote efficiency and allow for flexible, rapid-change production in response to vaccine and clinical trial demand. In 2025, many CMOs and CROs extended their flexible, modular production capacity. Over the next three to five years, the trend will continue to transition replace equipment with single-use plastics, in areas where equipment is needed but is not justifiable (i.e. low volume, short duration processing).
  • Sustainability Investment: Sustainability focuses on recyclability and the reduction of material, weight, and bio-based content of plastics. Manufacturers are focusing on waste segregation, energy efficient processes and solvent reduction as part of closure systems. The Packaging and Packaging Waste Regulation of the EU is effective from August 2026, creating an environment for improved packaging performance and recyclability. During the next three to five years, the market will expand reusable and closed-loop systems, and more transparent environmental communication.

The challenges facing this market include:

  • Regulatory Qualification: Biopharma plastics face many challenges such as meeting the strict requirements of sterility and biocompatibility, chemical and extractable and leachable compatibility. Every component and step of the manufacturing process can impact the quality of the final product. USP General Chapter 665 which takes effect in May 2026, will provide a recognized framework for assessment of plastic components used in the pharmaceutical and biopharmaceutical manufacturing. During the next three to five years there will be increased expectations for regulatory control, increased costs of testing, longer approval times, and favor suppliers who maintain strong systems for process and product control and quality assurance.
  • Environmental Waste: Disposable devices can generate large volumes of hard-to-recycle mixed-waste, especially if they contain biological or hazardous materials. Incineration is common, but increases emissions and costs. From August 2026, the European Union's Packaging and Packaging Waste Regulation will require improvements to packaging in 27 countries. Prior to 2025, other environmental legislation and sustainability goals should encourage manufacturers to use materials judiciously, improve product recyclability, and implement take-back systems, while justifying use of disposable devices by demonstrating their lifecycle benefits.
  • Cost and Supply Risks: Medical-grade resins and multilayer films can be expensive, and supply can be limited because of transport challenges, variability in the petrochemical industry and qualification delays.

It can be challenging to switch suppliers because new materials often need validation and regulatory documentation. In 2025, many manufacturers still had dual-source strategies for critical materials, with two qualified suppliers considered an acceptable resiliency strategy. In the next three to five years, costs and supply chain concentration will push manufacturers to implement regional production, long-term supply contracts, and an increase in the use of production buffers and standardization in the design of components.

List of Biopharma Plastic Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies biopharma plastic market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biopharma plastic market companies profiled in this report include-

  • BASF
  • LyondellBasell Industries Holdings
  • SABIC
  • LG Chem
  • Toray Industries
  • Solvay
  • Dow
  • DuPont de Nemours
  • Saint-Gobain Performance Plastics
  • Tekni-Plex

Biopharma Plastic Market by Segment

The study includes a forecast for the global biopharma plastic market by product type, application, and region.

Biopharma Plastic Market by Product Type [Value ($B) from 2019 to 2035]:

  • Polyethylene
  • Polypropylene
  • Acrylonitrile Butadiene Styrene
  • Polyethylene Terephthalate
  • Polyvinyl Chloride
  • Polytetrafluoroethylene
  • Polycarbonate
  • Others

Biopharma Plastic Market by Application [Value ($B) from 2019 to 2035]:

  • Protective Wear
  • Containers
  • Bioreactor Bags
  • Syringes
  • Depth Filters
  • Disposable Medical Connectors
  • Others

Biopharma Plastic Market by Region [Value ($B) from 2019 to 2035]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Biopharma Plastic Market

Biopharma plastic packaging is being transformed by injectable drugs, tighter extractables, and regional supply chain investments. From 2025-2027 drug makers and converters will partner resin qualification with ready to use components and recycling. Lucintel expects these changes will influence supplier positioning.

  • United States: Consolidation. Amcor's (now Berry) closing of the healthcare films, bottles, and closures package business on April 30, 2025, is expected to positively impact resin qualification for standardized plastic components in the next 3-5 years.
  • China: Domestic materials: In March 2025, Sinopec reported that medical-grade polypropylene from its petrochemical operations was being used in syringes and infusion sets, thereby supporting local production of validated medical plastics. The independence from imported grades can be useful to support domestic resin qualification and large-scale component manufacturing over the next 3-5 years.
  • Germany: Packaging consolidation: In January 2025, Gerresheimer completed its acquisition of Bormioli Pharma for a valuation of about €800 million. With this acquisition, Gerresheimer added pharmaceutical plastic containers and closures to its existing product portfolio. This acquisition is significant as combined customer base and tooling should strengthen Gerresheimer's position as a primary packaging supplier in Germany over the next 3-5 years.
  • India: Capacity localization: In 2025, Poly Medicure announced that it had set up a new manufacturing facility in India and plans to invest ₹350 crore to manufacture sterile disposables and other polymeric medical devices. This investment is significant as it provides domestic supply of components that are essential for medical devices, thus supporting local medical device manufacturing over the next 3-5 years.
  • Japan: Advanced components: Terumo announced its plans to expand and build new facilities in Japan to manufacture pre-filled syringes and drug delivery systems and to make an investment of ¥100 billion in 2025. The investment is significant as it strengthens Japan's domestic capacity to manufacture and qualify polymer components for medical devices and drug delivery systems over the next 10 years.

Features of the Global Biopharma Plastic Market

  • Market Size Estimates: biopharma plastic market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
  • Segmentation Analysis: biopharma plastic market size by product type, application, and region in terms of value ($B).
  • Regional Analysis: biopharma plastic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different product types, applications, and regions for the biopharma plastic market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biopharma plastic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the biopharma plastic market by product type (polyethylene, polypropylene, acrylonitrile butadiene styrene, polyethylene terephthalate, polyvinyl chloride, polytetrafluoroethylene, polycarbonate, and others), application (protective wear, containers, bioreactor bags, syringes, depth filters, disposable medical connectors, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Biopharma Plastic Market by Product Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Product Type
  • 4.3 Polyethylene : Trends and Forecast (2019 to 2035)
  • 4.4 Polypropylene : Trends and Forecast (2019 to 2035)
  • 4.5 Acrylonitrile Butadiene Styrene : Trends and Forecast (2019 to 2035)
  • 4.6 Polyethylene Terephthalate : Trends and Forecast (2019 to 2035)
  • 4.7 Polyvinyl Chloride : Trends and Forecast (2019 to 2035)
  • 4.8 Polytetrafluoroethylene : Trends and Forecast (2019 to 2035)
  • 4.9 Polycarbonate : Trends and Forecast (2019 to 2035)
  • 4.10 Others : Trends and Forecast (2019 to 2035)

5. Global Biopharma Plastic Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Protective Wear : Trends and Forecast (2019 to 2035)
  • 5.4 Containers : Trends and Forecast (2019 to 2035)
  • 5.5 Bioreactor Bags : Trends and Forecast (2019 to 2035)
  • 5.6 Syringes : Trends and Forecast (2019 to 2035)
  • 5.7 Depth Filters : Trends and Forecast (2019 to 2035)
  • 5.8 Disposable Medical Connectors : Trends and Forecast (2019 to 2035)
  • 5.9 Others : Trends and Forecast (2019 to 2035)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Biopharma Plastic Market by Region

7. North American Biopharma Plastic Market

  • 7.1 Overview
  • 7.2 North American Biopharma Plastic Market by Product Type
  • 7.3 North American Biopharma Plastic Market by Application
  • 7.4 The United States Biopharma Plastic Market
  • 7.5 Canadian Biopharma Plastic Market
  • 7.6 Mexican Biopharma Plastic Market

8. European Biopharma Plastic Market

  • 8.1 Overview
  • 8.2 European Biopharma Plastic Market by Product Type
  • 8.3 European Biopharma Plastic Market by Application
  • 8.4 German Biopharma Plastic Market
  • 8.5 French Biopharma Plastic Market
  • 8.6 Italian Biopharma Plastic Market
  • 8.7 Spanish Biopharma Plastic Market
  • 8.8 The United Kingdom Biopharma Plastic Market

9. APAC Biopharma Plastic Market

  • 9.1 Overview
  • 9.2 APAC Biopharma Plastic Market by Product Type
  • 9.3 APAC Biopharma Plastic Market by Application
  • 9.4 Chinese Biopharma Plastic Market
  • 9.5 Indian Biopharma Plastic Market
  • 9.6 Japanese Biopharma Plastic Market
  • 9.7 South Korean Biopharma Plastic Market
  • 9.8 Indonesian Biopharma Plastic Market

10. ROW Biopharma Plastic Market

  • 10.1 Overview
  • 10.2 ROW Biopharma Plastic Market by Product Type
  • 10.3 ROW Biopharma Plastic Market by Application
  • 10.4 Middle Eastern Biopharma Plastic Market
  • 10.5 South American Biopharma Plastic Market
  • 10.6 African Biopharma Plastic Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunity by Product Type
    • 12.2.2 Growth Opportunity by Application
  • 12.3 Emerging Trends in the Global Biopharma Plastic Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis Overview
  • 13.2 BASF
    • Company Overview
    • Biopharma Plastic Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 LyondellBasell Industries Holdings
    • Company Overview
    • Biopharma Plastic Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 SABIC
    • Company Overview
    • Biopharma Plastic Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 LG Chem
    • Company Overview
    • Biopharma Plastic Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 Toray Industries
    • Company Overview
    • Biopharma Plastic Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 Solvay
    • Company Overview
    • Biopharma Plastic Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 Dow
    • Company Overview
    • Biopharma Plastic Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.9 DuPont de Nemours
    • Company Overview
    • Biopharma Plastic Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.10 Saint-Gobain Performance Plastics
    • Company Overview
    • Biopharma Plastic Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.11 Tekni-Plex
    • Company Overview
    • Biopharma Plastic Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Biopharma Plastic Market
  • Figure 2.1: Usage of Biopharma Plastic Market
  • Figure 2.2: Classification of the Global Biopharma Plastic Market
  • Figure 2.3: Supply Chain of the Global Biopharma Plastic Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 3.19: Driver and Challenges of the Biopharma Plastic Market
  • Figure 4.1: Global Biopharma Plastic Market by Product Type in 2019, 2026, and 2035
  • Figure 4.2: Trends of the Global Biopharma Plastic Market ($B) by Product Type
  • Figure 4.3: Forecast for the Global Biopharma Plastic Market ($B) by Product Type
  • Figure 4.4: Trends and Forecast for Polyethylene in the Global Biopharma Plastic Market (2019-2035)
  • Figure 4.5: Trends and Forecast for Polypropylene in the Global Biopharma Plastic Market (2019-2035)
  • Figure 4.6: Trends and Forecast for Acrylonitrile Butadiene Styrene in the Global Biopharma Plastic Market (2019-2035)
  • Figure 4.7: Trends and Forecast for Polyethylene Terephthalate in the Global Biopharma Plastic Market (2019-2035)
  • Figure 4.8: Trends and Forecast for Polyvinyl Chloride in the Global Biopharma Plastic Market (2019-2035)
  • Figure 4.9: Trends and Forecast for Polytetrafluoroethylene in the Global Biopharma Plastic Market (2019-2035)
  • Figure 4.10: Trends and Forecast for Polycarbonate in the Global Biopharma Plastic Market (2019-2035)
  • Figure 4.11: Trends and Forecast for Others in the Global Biopharma Plastic Market (2019-2035)
  • Figure 5.1: Global Biopharma Plastic Market by Application in 2019, 2026, and 2035
  • Figure 5.2: Trends of the Global Biopharma Plastic Market ($B) by Application
  • Figure 5.3: Forecast for the Global Biopharma Plastic Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Protective Wear in the Global Biopharma Plastic Market (2019-2035)
  • Figure 5.5: Trends and Forecast for Containers in the Global Biopharma Plastic Market (2019-2035)
  • Figure 5.6: Trends and Forecast for Bioreactor Bags in the Global Biopharma Plastic Market (2019-2035)
  • Figure 5.7: Trends and Forecast for Syringes in the Global Biopharma Plastic Market (2019-2035)
  • Figure 5.8: Trends and Forecast for Depth Filters in the Global Biopharma Plastic Market (2019-2035)
  • Figure 5.9: Trends and Forecast for Disposable Medical Connectors in the Global Biopharma Plastic Market (2019-2035)
  • Figure 5.10: Trends and Forecast for Others in the Global Biopharma Plastic Market (2019-2035)
  • Figure 6.1: Trends of the Global Biopharma Plastic Market ($B) by Region (2019-2026)
  • Figure 6.2: Forecast for the Global Biopharma Plastic Market ($B) by Region (2027-2035)
  • Figure 7.1: Trends and Forecast for the North American Biopharma Plastic Market (2019-2035)
  • Figure 7.2: North American Biopharma Plastic Market by Product Type in 2019, 2026, and 2035
  • Figure 7.3: Trends of the North American Biopharma Plastic Market ($B) by Product Type (2019-2026)
  • Figure 7.4: Forecast for the North American Biopharma Plastic Market ($B) by Product Type (2027-2035)
  • Figure 7.5: North American Biopharma Plastic Market by Application in 2019, 2026, and 2035
  • Figure 7.6: Trends of the North American Biopharma Plastic Market ($B) by Application (2019-2026)
  • Figure 7.7: Forecast for the North American Biopharma Plastic Market ($B) by Application (2027-2035)
  • Figure 7.8: Trends and Forecast for the United States Biopharma Plastic Market ($B) (2019-2035)
  • Figure 7.9: Trends and Forecast for the Mexican Biopharma Plastic Market ($B) (2019-2035)
  • Figure 7.10: Trends and Forecast for the Canadian Biopharma Plastic Market ($B) (2019-2035)
  • Figure 8.1: Trends and Forecast for the European Biopharma Plastic Market (2019-2035)
  • Figure 8.2: European Biopharma Plastic Market by Product Type in 2019, 2026, and 2035
  • Figure 8.3: Trends of the European Biopharma Plastic Market ($B) by Product Type (2019-2026)
  • Figure 8.4: Forecast for the European Biopharma Plastic Market ($B) by Product Type (2027-2035)
  • Figure 8.5: European Biopharma Plastic Market by Application in 2019, 2026, and 2035
  • Figure 8.6: Trends of the European Biopharma Plastic Market ($B) by Application (2019-2026)
  • Figure 8.7: Forecast for the European Biopharma Plastic Market ($B) by Application (2027-2035)
  • Figure 8.8: Trends and Forecast for the German Biopharma Plastic Market ($B) (2019-2035)
  • Figure 8.9: Trends and Forecast for the French Biopharma Plastic Market ($B) (2019-2035)
  • Figure 8.10: Trends and Forecast for the Spanish Biopharma Plastic Market ($B) (2019-2035)
  • Figure 8.11: Trends and Forecast for the Italian Biopharma Plastic Market ($B) (2019-2035)
  • Figure 8.12: Trends and Forecast for the United Kingdom Biopharma Plastic Market ($B) (2019-2035)
  • Figure 9.1: Trends and Forecast for the APAC Biopharma Plastic Market (2019-2035)
  • Figure 9.2: APAC Biopharma Plastic Market by Product Type in 2019, 2026, and 2035
  • Figure 9.3: Trends of the APAC Biopharma Plastic Market ($B) by Product Type (2019-2026)
  • Figure 9.4: Forecast for the APAC Biopharma Plastic Market ($B) by Product Type (2027-2035)
  • Figure 9.5: APAC Biopharma Plastic Market by Application in 2019, 2026, and 2035
  • Figure 9.6: Trends of the APAC Biopharma Plastic Market ($B) by Application (2019-2026)
  • Figure 9.7: Forecast for the APAC Biopharma Plastic Market ($B) by Application (2027-2035)
  • Figure 9.8: Trends and Forecast for the Japanese Biopharma Plastic Market ($B) (2019-2035)
  • Figure 9.9: Trends and Forecast for the Indian Biopharma Plastic Market ($B) (2019-2035)
  • Figure 9.10: Trends and Forecast for the Chinese Biopharma Plastic Market ($B) (2019-2035)
  • Figure 9.11: Trends and Forecast for the South Korean Biopharma Plastic Market ($B) (2019-2035)
  • Figure 9.12: Trends and Forecast for the Indonesian Biopharma Plastic Market ($B) (2019-2035)
  • Figure 10.1: Trends and Forecast for the ROW Biopharma Plastic Market (2019-2035)
  • Figure 10.2: ROW Biopharma Plastic Market by Product Type in 2019, 2026, and 2035
  • Figure 10.3: Trends of the ROW Biopharma Plastic Market ($B) by Product Type (2019-2026)
  • Figure 10.4: Forecast for the ROW Biopharma Plastic Market ($B) by Product Type (2027-2035)
  • Figure 10.5: ROW Biopharma Plastic Market by Application in 2019, 2026, and 2035
  • Figure 10.6: Trends of the ROW Biopharma Plastic Market ($B) by Application (2019-2026)
  • Figure 10.7: Forecast for the ROW Biopharma Plastic Market ($B) by Application (2027-2035)
  • Figure 10.8: Trends and Forecast for the Middle Eastern Biopharma Plastic Market ($B) (2019-2035)
  • Figure 10.9: Trends and Forecast for the South American Biopharma Plastic Market ($B) (2019-2035)
  • Figure 10.10: Trends and Forecast for the African Biopharma Plastic Market ($B) (2019-2035)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Biopharma Plastic Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Biopharma Plastic Market (2026)
  • Figure 12.1: Growth Opportunities for the Global Biopharma Plastic Market by Product Type
  • Figure 12.2: Growth Opportunities for the Global Biopharma Plastic Market by Application
  • Figure 12.3: Growth Opportunities for the Global Biopharma Plastic Market by Region
  • Figure 12.4: Emerging Trends in the Global Biopharma Plastic Market

List of Tables

  • Table 1.1: Growth Rate (%, 2025-2026) and CAGR (%, 2027-2035) of the Biopharma Plastic Market by Product Type and Application
  • Table 1.2: Attractiveness Analysis for the Biopharma Plastic Market by Region
  • Table 1.3: Global Biopharma Plastic Market Parameters and Attributes
  • Table 3.1: Trends of the Global Biopharma Plastic Market (2019-2026)
  • Table 3.2: Forecast for the Global Biopharma Plastic Market (2027-2035)
  • Table 4.1: Attractiveness Analysis for the Global Biopharma Plastic Market by Product Type
  • Table 4.2: Market Size and CAGR of Various Product Type in the Global Biopharma Plastic Market (2019-2026)
  • Table 4.3: Market Size and CAGR of Various Product Type in the Global Biopharma Plastic Market (2027-2035)
  • Table 4.4: Trends of Polyethylene in the Global Biopharma Plastic Market (2019-2026)
  • Table 4.5: Forecast for Polyethylene in the Global Biopharma Plastic Market (2027-2035)
  • Table 4.6: Trends of Polypropylene in the Global Biopharma Plastic Market (2019-2026)
  • Table 4.7: Forecast for Polypropylene in the Global Biopharma Plastic Market (2027-2035)
  • Table 4.8: Trends of Acrylonitrile Butadiene Styrene in the Global Biopharma Plastic Market (2019-2026)
  • Table 4.9: Forecast for Acrylonitrile Butadiene Styrene in the Global Biopharma Plastic Market (2027-2035)
  • Table 4.10: Trends of Polyethylene Terephthalate in the Global Biopharma Plastic Market (2019-2026)
  • Table 4.11: Forecast for Polyethylene Terephthalate in the Global Biopharma Plastic Market (2027-2035)
  • Table 4.12: Trends of Polyvinyl Chloride in the Global Biopharma Plastic Market (2019-2026)
  • Table 4.13: Forecast for Polyvinyl Chloride in the Global Biopharma Plastic Market (2027-2035)
  • Table 4.14: Trends of Polytetrafluoroethylene in the Global Biopharma Plastic Market (2019-2026)
  • Table 4.15: Forecast for Polytetrafluoroethylene in the Global Biopharma Plastic Market (2027-2035)
  • Table 4.16: Trends of Polycarbonate in the Global Biopharma Plastic Market (2019-2026)
  • Table 4.17: Forecast for Polycarbonate in the Global Biopharma Plastic Market (2027-2035)
  • Table 4.18: Trends of Others in the Global Biopharma Plastic Market (2019-2026)
  • Table 4.19: Forecast for Others in the Global Biopharma Plastic Market (2027-2035)
  • Table 5.1: Attractiveness Analysis for the Global Biopharma Plastic Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Biopharma Plastic Market (2019-2026)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Biopharma Plastic Market (2027-2035)
  • Table 5.4: Trends of Protective Wear in the Global Biopharma Plastic Market (2019-2026)
  • Table 5.5: Forecast for Protective Wear in the Global Biopharma Plastic Market (2027-2035)
  • Table 5.6: Trends of Containers in the Global Biopharma Plastic Market (2019-2026)
  • Table 5.7: Forecast for Containers in the Global Biopharma Plastic Market (2027-2035)
  • Table 5.8: Trends of Bioreactor Bags in the Global Biopharma Plastic Market (2019-2026)
  • Table 5.9: Forecast for Bioreactor Bags in the Global Biopharma Plastic Market (2027-2035)
  • Table 5.10: Trends of Syringes in the Global Biopharma Plastic Market (2019-2026)
  • Table 5.11: Forecast for Syringes in the Global Biopharma Plastic Market (2027-2035)
  • Table 5.12: Trends of Depth Filters in the Global Biopharma Plastic Market (2019-2026)
  • Table 5.13: Forecast for Depth Filters in the Global Biopharma Plastic Market (2027-2035)
  • Table 5.14: Trends of Disposable Medical Connectors in the Global Biopharma Plastic Market (2019-2026)
  • Table 5.15: Forecast for Disposable Medical Connectors in the Global Biopharma Plastic Market (2027-2035)
  • Table 5.16: Trends of Others in the Global Biopharma Plastic Market (2019-2026)
  • Table 5.17: Forecast for Others in the Global Biopharma Plastic Market (2027-2035)"
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Biopharma Plastic Market (2019-2026)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Biopharma Plastic Market (2027-2035)
  • Table 7.1: Trends of the North American Biopharma Plastic Market (2019-2026)
  • Table 7.2: Forecast for the North American Biopharma Plastic Market (2027-2035)
  • Table 7.3: Market Size and CAGR of Various Product Type in the North American Biopharma Plastic Market (2019-2026)
  • Table 7.4: Market Size and CAGR of Various Product Type in the North American Biopharma Plastic Market (2027-2035)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Biopharma Plastic Market (2019-2026)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Biopharma Plastic Market (2027-2035)
  • Table 7.7: Trends and Forecast for the United States Biopharma Plastic Market (2019-2035)
  • Table 7.8: Trends and Forecast for the Mexican Biopharma Plastic Market (2019-2035)
  • Table 7.9: Trends and Forecast for the Canadian Biopharma Plastic Market (2019-2035)
  • Table 8.1: Trends of the European Biopharma Plastic Market (2019-2026)
  • Table 8.2: Forecast for the European Biopharma Plastic Market (2027-2035)
  • Table 8.3: Market Size and CAGR of Various Product Type in the European Biopharma Plastic Market (2019-2026)
  • Table 8.4: Market Size and CAGR of Various Product Type in the European Biopharma Plastic Market (2027-2035)
  • Table 8.5: Market Size and CAGR of Various Application in the European Biopharma Plastic Market (2019-2026)
  • Table 8.6: Market Size and CAGR of Various Application in the European Biopharma Plastic Market (2027-2035)
  • Table 8.7: Trends and Forecast for the German Biopharma Plastic Market (2019-2035)
  • Table 8.8: Trends and Forecast for the French Biopharma Plastic Market (2019-2035)
  • Table 8.9: Trends and Forecast for the Spanish Biopharma Plastic Market (2019-2035)
  • Table 8.10: Trends and Forecast for the Italian Biopharma Plastic Market (2019-2035)
  • Table 8.11: Trends and Forecast for the United Kingdom Biopharma Plastic Market (2019-2035)
  • Table 9.1: Trends of the APAC Biopharma Plastic Market (2019-2026)
  • Table 9.2: Forecast for the APAC Biopharma Plastic Market (2027-2035)
  • Table 9.3: Market Size and CAGR of Various Product Type in the APAC Biopharma Plastic Market (2019-2026)
  • Table 9.4: Market Size and CAGR of Various Product Type in the APAC Biopharma Plastic Market (2027-2035)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Biopharma Plastic Market (2019-2026)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Biopharma Plastic Market (2027-2035)
  • Table 9.7: Trends and Forecast for the Japanese Biopharma Plastic Market (2019-2035)
  • Table 9.8: Trends and Forecast for the Indian Biopharma Plastic Market (2019-2035)
  • Table 9.9: Trends and Forecast for the Chinese Biopharma Plastic Market (2019-2035)
  • Table 9.10: Trends and Forecast for the South Korean Biopharma Plastic Market (2019-2035)
  • Table 9.11: Trends and Forecast for the Indonesian Biopharma Plastic Market (2019-2035)
  • Table 10.1: Trends of the ROW Biopharma Plastic Market (2019-2026)
  • Table 10.2: Forecast for the ROW Biopharma Plastic Market (2027-2035)
  • Table 10.3: Market Size and CAGR of Various Product Type in the ROW Biopharma Plastic Market (2019-2026)
  • Table 10.4: Market Size and CAGR of Various Product Type in the ROW Biopharma Plastic Market (2027-2035)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Biopharma Plastic Market (2019-2026)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Biopharma Plastic Market (2027-2035)
  • Table 10.7: Trends and Forecast for the Middle Eastern Biopharma Plastic Market (2019-2035)
  • Table 10.8: Trends and Forecast for the South American Biopharma Plastic Market (2019-2035)
  • Table 10.9: Trends and Forecast for the African Biopharma Plastic Market (2019-2035)
  • Table 11.1: Product Mapping of Biopharma Plastic Suppliers Based on Segments
  • Table 11.2: Operational Integration of Biopharma Plastic Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Biopharma Plastic Revenue
  • Table 12.1: New Product Launches by Major Biopharma Plastic Producers (2019-2026)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Biopharma Plastic Market
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!